(NASDAQ: TFFP) Tff Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.31%.
Tff Pharmaceuticals's earnings in 2024 is -$18,521,712.On average, 1 Wall Street analyst forecast TFFP's earnings for 2024 to be -$19,016,215, with the lowest TFFP earnings forecast at -$19,016,215, and the highest TFFP earnings forecast at -$19,016,215. On average, 1 Wall Street analyst forecast TFFP's earnings for 2025 to be -$16,750,265, with the lowest TFFP earnings forecast at -$16,750,265, and the highest TFFP earnings forecast at -$16,750,265.
In 2026, TFFP is forecast to generate -$12,040,641 in earnings, with the lowest earnings forecast at -$12,040,641 and the highest earnings forecast at -$12,040,641.